<DOC>
	<DOCNO>NCT01798511</DOCNO>
	<brief_summary>Acute pancreatitis ( AP ) one common diseases routine clinical practice surgeon gastroenterologist throughout world . The high rate pain relapse oral refeeding contributes high consumption healthcare resource prolong hospital stay AP patient . The data pilot MIMOSA trial suggest early administration nasogastric tube feed may prevent pain relapse oral refeeding AP . The potential beneficial effect enteral tube feed include induction postprandial gastrointestinal motility improve tolerance oral refeeding . This may reduce risk pain relapse , thereby shorten length hospital stay reduce cost treatment . The primary endpoint ORION trial incidence oral food intolerance . All eligible AP patient randomly allocate either Early Nasogastric Tube ( ENT ) group Conventional Nutritional Management group ( CNM ) 24h hospital admission .</brief_summary>
	<brief_title>Oral Refeeding IntOlerance After Nasogastric Tube Feeding ( ORION )</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<criteria>Diagnosis AP Age 18 year old Written inform consent Ongoing need opiates 96 hour onset symptom Chronic pancreatitis PostERCP pancreatitis Intraoperative diagnosis Pregnancy Malignancy Received nutrition randomisation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>enteral nutrition</keyword>
	<keyword>acute pancreatitis</keyword>
	<keyword>oral food intolerance</keyword>
</DOC>